Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy.

Mark P SittigMichael LuuEmi J YoshidaKevin ScherAlain MitaStephen L ShiaoDiana J LuJon Mallen-St ClairAllen S HoZachary S Zumsteg

Published in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2019)

Patients <65 with HNSCC undergoing definitive radiation with private health insurance have markedly longer survival relative to patients with government-sponsored insurance. This illustrates that increasing access to care may be necessary, but is not sufficient, to mitigate the significant disparities in the US healthcare system.

Keyphrases

health insurance
affordable care act
locally advanced
papillary thyroid
healthcare
free survival
early stage
radiation induced
radiation therapy
squamous cell
palliative care
squamous cell carcinoma
quality improvement
chronic pain
rectal cancer